VR Adviser, LLC
data from 31/03/2026
Capitalization
Portfolio size
Portfolio performance
Portfolio performance %
Performance compared to S&P 500 (%)
Stock in VR Adviser, LLC
| Date | Ticket | Name | Weight | Capitalization | Share number | First added | Performance ($) | Performance (%) |
|---|---|---|---|---|---|---|---|---|
| 2026/03/31 | APGE | APOGEE THERAPEUTICS INC | 26.68% | 714.883 M $ | 8493321 | 2023/09/30 | 73.807 M $ | 11.51 % |
| 2026/03/31 | ERAS | ERASCA INC | 9.89% | 265.074 M $ | 16382812 | 2024/06/30 | 222.499 M $ | 334.95 % |
| 2026/03/31 | ORKA | ORUKA THERAPEUTICS INC | 7.60% | 203.480 M $ | 4148428 | 2024/09/30 | 77.742 M $ | 61.83 % |
| 2026/03/31 | SYRE | SPYRE THERAPEUTICS INC | 6.94% | 185.894 M $ | 3685448 | 2023/12/31 | 65.159 M $ | 53.97 % |
| 2026/03/31 | KALV | KALVISTA PHARMACEUTICALS INC | 4.86% | 130.331 M $ | 6474485 | 2022/12/31 | 26.781 M $ | 24.64 % |
| 2026/03/31 | DNTH | DIANTHUS THERAPEUTICS INC | 3.70% | 99.026 M $ | 1180000 | 2023/09/30 | 42.710 M $ | 103.64 % |
| 2026/03/31 | DMRA | DAMORA THERAPEUTICS INC | 3.48% | 93.333 M $ | 3603595 | 2026/03/31 | 0.000 $ | 0.00 % |
| 2026/03/31 | OCUL | OCULAR THERAPEUTIX INC | 3.27% | 87.638 M $ | 10346926 | 2023/12/31 | -26.848 M $ | -30.23 % |
| 2026/03/31 | COGT | COGENT BIOSCIENCES INC | 2.87% | 76.980 M $ | 2000000 | 2020/12/31 | 5.940 M $ | 8.36 % |
| 2026/03/31 | VRDN | VIRIDIAN THERAPEUTICS INC | 2.83% | 75.946 M $ | 3882709 | 2020/12/31 | -44.884 M $ | -37.15 % |
| 2026/03/31 | SVRA | SAVARA INC | 2.80% | 75.022 M $ | 13740375 | 2025/03/31 | -7.832 M $ | -9.45 % |
| 2026/03/31 | ELVN | ENLIVEN THERAPEUTICS INC | 2.53% | 67.672 M $ | 1726331 | 2023/03/31 | 76.787 M $ | 154.55 % |
| 2026/03/31 | ORIC | ORIC PHARMACEUTICALS INC | 2.04% | 54.731 M $ | 4319765 | 2023/06/30 | 25.486 M $ | 54.89 % |
| 2026/03/31 | VOR | VOR BIOPHARMA INC | 2.03% | 54.264 M $ | 3041719 | 2025/09/30 | 9.252 M $ | 36.39 % |
| 2026/03/31 | MAZE | MAZE THERAPEUTICS INC | 1.78% | 47.821 M $ | 1602034 | 2025/09/30 | -17.932 M $ | -27.95 % |
| 2026/03/31 | CTMX | CYTOMX THERAPEUTICS INC | 1.75% | 46.916 M $ | 9982124 | 2025/06/30 | 6.847 M $ | 10.33 % |
| 2026/03/31 | JBIO | JADE BIOSCIENCES INC | 1.69% | 45.246 M $ | 3220364 | 2025/06/30 | -4.444 M $ | -8.94 % |
| 2026/03/31 | DYN | DYNE THERAPEUTICS INC | 1.47% | 39.413 M $ | 2173913 | 2023/06/30 | -3.109 M $ | -7.31 % |
| 2026/03/31 | CBIO | CRESCENT BIOPHARMA INC. | 1.46% | 39.194 M $ | 2133576 | 2025/06/30 | 13.890 M $ | 54.89 % |
| 2026/03/31 | ZURA | ZURA BIO LTD | 1.43% | 38.288 M $ | 6434990 | 2024/06/30 | 3.795 M $ | 13.55 % |
| 2026/03/31 | RLMD | RELMADA THERAPEUTICS INC | 1.26% | 33.710 M $ | 4843380 | 2026/03/31 | 0.000 $ | 0.00 % |
| 2026/03/31 | ENGN | ENGENE HOLDINGS INC | 1.21% | 32.493 M $ | 4771414 | 2024/03/31 | -10.593 M $ | -24.58 % |
| 2026/03/31 | TENX | TENAX THERAPEUTICS INC | 1.00% | 26.787 M $ | 1675262 | 2024/09/30 | 0.000 $ | 0.00 % |
| 2026/03/31 | ANL | ADLAI NORTYE LTD | 0.83% | 22.232 M $ | 3212731 | 2026/03/31 | 0.000 $ | 0.00 % |
| 2026/03/31 | IPSC | CENTURY THERAPEUTICS INC | 0.73% | 19.652 M $ | 8695652 | 2026/03/31 | 0.000 $ | 0.00 % |
| 2026/03/31 | CGEM | CULLINAN THERAPEUTICS INC | 0.73% | 19.609 M $ | 1379965 | 2024/06/30 | 5.327 M $ | 37.29 % |
| 2026/03/31 | CYBIN INC | 0.69% | 18.488 M $ | 3851654 | 2025/12/31 | -12.980 M $ | -41.32 % | |
| 2026/03/31 | SRZN | SURROZEN INC | 0.69% | 18.437 M $ | 632931 | 2025/03/31 | 4.133 M $ | 28.89 % |
| 2026/03/31 | SEPN | SEPTERNA INC | 0.45% | 12.161 M $ | 506056 | 2025/06/30 | -2.352 M $ | -13.81 % |
| 2026/03/31 | KRRO | KORRO BIO INC | 0.43% | 11.428 M $ | 1009500 | 2026/03/31 | 0.000 $ | 0.00 % |
| 2026/03/31 | ANRO | ALTO NEUROSCIENCE INC | 0.42% | 11.240 M $ | 500000 | 2026/03/31 | 0.000 $ | 0.00 % |
| 2026/03/31 | ARTV | ARTIVA BIOTHERAPEUTICS INC | 0.39% | 10.366 M $ | 1609569 | 2024/09/30 | 3.461 M $ | 50.12 % |
| 2026/03/31 | XFOR | X4 PHARMACEUTICALS INC | 0.05% | 1.365 M $ | 330525 | 2026/03/31 | 0.000 $ | 0.00 % |
| 2026/03/31 | UPB | UPSTREAM BIO INC | 0.00% | 0.000 $ | 0 | 2024/12/31 | 0.000 $ | 0.00 % |
| 2026/03/31 | CASI | CASI PHARMACEUTICALS INC | 0.00% | 0.000 $ | 0 | 2024/06/30 | 0.000 $ | 0.00 % |